With gratitude always, Jackie Giannelli, FNP-BC, MSCP Founder, In the Saddle What did you think of today's newsletter
However, consult your healthcare provider before starting supplementation, especially if you have kidney disease or take other medications
The institute recommended that existing GLP-1 makers, and those with products in the pipeline, should consider steep discounts to prices in exchange for higher volume. What has to happen is we have to move from a low-volume, high-price business model, to a high-volume, low-price business model, Nunn said
Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), are increasingly prescribed for weight management in the UK